ストックスクリーナーアプリを入手
0.083
10.08%
-0.0093
アフターアワーズ：
.08
-0.003
-3.61%
前日終値:
$0.0923
開ける：
$0.089
24時間の取引高:
11.56M
Relative Volume:
2.86
時価総額：
$2.21M
収益：
$1.44M
当期純損益:
$-3.21M
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
-21.99%
1か月 パフォーマンス:
-68.84%
6か月 パフォーマンス:
-88.06%
1年 パフォーマンス:
+0.00%
1日の値動き範囲:
$0.0821
$0.091
1週間の範囲:
$0.0821
$0.113
52週間の値動き範囲:
$0.0821
$4.2442
Elevai Labs Inc Stock (ELAB) Company Profile
Elevai Labs Inc (ELAB) 最新ニュース
What is ELAB’s price-to-sales ratio telling us about the company’s value? - US Post News
Elevai Labs Inc. [ELAB] Revenue clocked in at $2.47 million, down -94.95% YTD: What’s Next? - The DBT News
In the Green: Elevai Labs Inc. (ELAB) Closes at 0.09, Up/Down 3.71 from Previous Day - The Dwinnex
Elevai Labs Inc.’s Banking’s 100-Day Moving Average at 0.4636: Will the Stock Break Through? - The InvestChronicle
Biotech Alert: Searches spiking for these stocks today - TipRanks
Altium Capital Management LP Acquires New Stake in Elevai Labs Inc - Yahoo Finance
Elevai Labs stock offering raises $8 million - The Business Journals
Altium Capital Management LP Acquires New Stake in Elevai Labs I - GuruFocus.com
Univest Securities, LLC Announces Closing of $8.0 Million - GlobeNewswire
Univest Securities, LLC Announces Closing of $8.0 Million Registered Follow-on Offering for its Client Elevai Labs Inc. (NASDAQ: ELAB) - ForexTV.com
Evolus Inc (EOLS) may enjoy gains as insiders got busy in the recent days - Knox Daily
Univest Securities, LLC Announces Closing of $8.0 Million Registered Follow-on Offering for its Client Elevai Labs Inc. (NASDAQ: ELAB) - Yahoo Finance UK
Evolv Technologies (NASDAQ:EVLV) Shares Down 2.9% - Defense World
EverSource Wealth Advisors LLC Raises Stock Position in Elevance Health, Inc. (NYSE:ELV) - Defense World
Enliven Therapeutics (NASDAQ:ELVN) Shares Gap Down to $23.57 - MarketBeat
Logos Global Management LP Lowers Holdings in Enliven Therapeutics, Inc. (NASDAQ:ELVN) - Defense World
First Light Asset Management LLC Has $27.63 Million Stake in Evolent Health, Inc. (NYSE:EVH) - Defense World
Evolv Technologies Holdings Inc (EVLV) looking to reclaim success with recent performance - SETE News
Stock Market Recap: Evolus Inc (EOLS) Concludes at 15.53, a -6.16 Surge/Decline - The Dwinnex
Check out these key findings about Elevation Oncology Inc (ELEV) - SETE News
SEC Form 424B3 filed by Elevai Labs Inc. - Quantisnow
Lombard Odier Asset Management Europe Ltd Invests $2.51 Million in Elevance Health, Inc. (NYSE:ELV) - Defense World
What is Elevai Labs Inc. (ELAB) Stock Return on Shareholders’ Capital? - SETE News
Pacer Advisors Inc. Decreases Stock Position in Elevance Health, Inc. (NYSE:ELV) - Defense World
Distillate Capital Partners LLC Grows Position in Elevance Health, Inc. (NYSE:ELV) - MarketBeat
Rhumbline Advisers Acquires 17,442 Shares of Evolus, Inc. (NASDAQ:EOLS) - Defense World
Victory Capital Management Inc. Sells 414,447 Shares of Evolent Health, Inc. (NYSE:EVH) - MarketBeat
Elementis (OTCMKTS:ELMTY) Sets New 52-Week High at $8.76 - Defense World
Elevai Labs shares tumble on pricing of new stock offering - The Business Journals
Elevance Health, Inc. (NYSE:ELV) Position Boosted by Magnetar Financial LLC - Defense World
Dow Gains Over 50 Points; Elevai Labs Shares Plummet - Benzinga
Decoding Elevance Health's Options Activity: What's the Big Picture? - Benzinga
Elevai Labs Inc. (ELAB) Stock: Navigating a Year of Stock Volatility - The InvestChronicle
ELAB’s price-to-free cash flow ratio: What it means for investors - US Post News
Perhaps timely catching Enliven Therapeutics Inc (ELVN) would be a good idea - SETE News
Ratios in Focus: Analyzing Elevation Oncology Inc (ELEV)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex
Elevai Labs prices public offering at $8 million By Investing.com - Investing.com Canada
Why Elevai Labs (ELAB) Stock Is Down 60% Today - Benzinga
Investing in Elevation Oncology Inc (ELEV) might be a great opportunity, but the stock is a bit undervalued - US Post News
Baltic Fintech Eleving To Raise Up To €30M In IPO - Law360
Xponance Inc. Sells 168 Shares of Elevance Health, Inc. (NYSE:ELV) - Defense World
Elevai Labs prices public offering at $8 million - Investing.com
Market Highlights: Elevai Labs Inc. (ELAB) Ends on a Low Note at 0.28 - The Dwinnex
Elevai Labs announces pricing of $8 million public offering - MSN
Elevai Labs to sell 28.6M shares at 28c in public offering - TipRanks
Ensign Peak Advisors Inc Acquires 2,862 Shares of Elevance Health, Inc. (NYSE:ELV) - Defense World
Elevai Labs Inc. Announces Pricing of $8.0 Million Public Offering - The Bakersfield Californian
Elevai Labs Inc. Announces Pricing of $8.0 Million Public Offering - GlobeNewswire
Elevai Labs Inc. Announces Pricing of $8.0 Million Public Offering - StockTitan
Elevar Therapeutics Resubmits New Drug Application to FDA for Combination of Camrelizumab plus Rivoceranib as First-Line Treatment Option for Unresectable Hepatocellular Carcinoma Boosted by CARES-310 Leading Overall Survival Analysis - ForexTV.com
How should investors view Evolv Technologies Holdings Inc (EVLV)? - US Post News
Elevai Labs Inc (ELAB) 財務データ
収益
当期純利益
現金流量
EPS
0.05%
4.86%
大文字化:
|
ボリューム (24 時間):